You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemoresponse

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multi-layer Data to Improve Diagnosis, Predict Therapy

Recruiting
  • High Grade Ovarian Serous Adenocarcinoma
  • WGS and RNA sequencing
  • +2 more
  • Turku, Finland
    Turku University Hospital
Apr 26, 2022

Lung Cancer, Organoid Trial in Geneva (Lung tumor resection)

Recruiting
  • Lung Cancer
  • Organoid
  • Lung tumor resection
  • Geneva, Switzerland
    Geneva University Hospitals
Jun 6, 2019

Breast Cancer Trial in Canada, Puerto Rico, United States (bevacizumab, capecitabine, cyclophosphamide)

Unknown status
Has Results
  • Breast Cancer
  • bevacizumab
  • +5 more
  • Little Rock, Arkansas
  • +441 more
Sep 12, 2017

ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry

Terminated
  • Solid Organ Tumors
    • Birmingham, Alabama
    • +24 more
    Oct 4, 2012

    Chemoresponse Assay With PFS in Recurrent Epithelial Ovarian,

    Terminated
    • Ovarian Cancer
    • +2 more
      • Irvine, California
      • +35 more
      Oct 4, 2012

      Neoadjuvant Chemotherapy in Women With Operable Breast Cancer

      Terminated
      • Breast Cancer
      • ChemoFX Assay
      • Long Beach, California
      • +27 more
      Oct 4, 2012

      ChemoFx® PRO - A Post-Market Data Collection Study

      Terminated
      • Ovarian Cancer
      • +7 more
        • Birmingham, Alabama
        • +66 more
        Oct 4, 2012

        Test in Ovarian, Peritoneal or Fallopian Cancer Cases

        Completed
        • Ovarian Cancer
        • +2 more
        • ChemoFx
        • Pittsburgh, Pennsylvania
          Precision Therapeutics, Inc.
        Jun 2, 2011

        Compared to ChemoFx Assay in Endometrial Cancer Patients

        Completed
        • Endometrial Cancer
        • ChemoFx
        • Pittsburgh, Pennsylvania
          Precision Therapeutics, Inc.
        Mar 14, 2011

        (SNP) Array-based Approach to Predict Chemoresponse and Survival

        Unknown status
        • Acute Lymphoblastic Leukemia
          • Seoul, Korea, Republic of
            Samsung Medical Center
          Mar 2, 2010

          Genome-wide Pharmacogenetic Candidate Gene Single Nucleotide

          Unknown status
          • Myeloid Leukemia
            • Seoul, Korea, Republic of
              Samsung Medical Center
            Feb 17, 2010